These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25118082)

  • 1. Risperidone-associated urinary incontinence in patients with autistic disorder with mental retardation.
    Kumazaki H; Watanabe K; Imasaka Y; Iwata K; Tomoda A; Mimura M
    J Clin Psychopharmacol; 2014 Oct; 34(5):624-6. PubMed ID: 25118082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone and double incontinence in a child with autism.
    Cop E; Oner P; Oner O
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):647-8. PubMed ID: 22136093
    [No Abstract]   [Full Text] [Related]  

  • 3. Risperidone-induced double incontinence.
    Hergüner S; Mukaddes NM
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1085-6. PubMed ID: 18387724
    [No Abstract]   [Full Text] [Related]  

  • 4. Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.
    Hellings JA; Zarcone JR; Crandall K; Wallace D; Schroeder SR
    J Child Adolesc Psychopharmacol; 2001; 11(3):229-38. PubMed ID: 11642473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone-induced enuresis in two children with autistic disorder.
    Hergüner S; Mukaddes NM
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):527-30. PubMed ID: 17822346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate-decreasing effects of the atypical neuroleptic risperidone attenuated by conditions of reinforcement in a woman with mental retardation.
    Yoo JH; Williams DC; Napolitano DA; Peyton RT; Baer DM; Schroeder SR
    J Appl Behav Anal; 2003; 36(2):245-8. PubMed ID: 12858988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone and explosive aggressive autism.
    Horrigan JP; Barnhill LJ
    J Autism Dev Disord; 1997 Jun; 27(3):313-23. PubMed ID: 9229261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary incontinence with risperidone.
    Agarwal V
    J Clin Psychiatry; 2000 Mar; 61(3):219. PubMed ID: 10817112
    [No Abstract]   [Full Text] [Related]  

  • 9. Incontinence after piperacetazine treatment.
    Lowenstein H
    Can Psychiatr Assoc J; 1973 Apr; 18(2):173. PubMed ID: 4145184
    [No Abstract]   [Full Text] [Related]  

  • 10. Examining risperidone use in those diagnosed with autism 1 year after FDA approval.
    Valdovinos MG; Bailey L; Taylor SL
    J Clin Psychiatry; 2010 May; 71(5):651-2. PubMed ID: 20492856
    [No Abstract]   [Full Text] [Related]  

  • 11. Weight gain with risperidone among patients with mental retardation: effect of calorie restriction.
    Cohen S; Glazewski R; Khan S; Khan A
    J Clin Psychiatry; 2001 Feb; 62(2):114-6. PubMed ID: 11247096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A crossover study of risperidone in children, adolescents and adults with mental retardation.
    Hellings JA; Zarcone JR; Reese RM; Valdovinos MG; Marquis JG; Fleming KK; Schroeder SR
    J Autism Dev Disord; 2006 Apr; 36(3):401-11. PubMed ID: 16596465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open clinical trial of risperidone monotherapy in young children with autistic disorder.
    Findling RL; Maxwell K; Wiznitzer M
    Psychopharmacol Bull; 1997; 33(1):155-9. PubMed ID: 9133768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case report. Risperidone induced fecal incontinence as a result of reduced anal sphincter tonus].
    Lundin F; Rousseau A; Kadowaki A
    Lakartidningen; 2004 Dec; 101(49):4006, 4008. PubMed ID: 15633339
    [No Abstract]   [Full Text] [Related]  

  • 15. Risperidone for the treatment of fecal smearing in a developmentally disabled adult.
    Brahm NC; Farmer KC; Brown RC
    Am J Health Syst Pharm; 2007 Feb; 64(4):382-4. PubMed ID: 17299177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone-induced paroxysmal perceptual alteration in a child with autism.
    Bozkurt H; Ayaydın H; Adak İ; Zoroğlu SS
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):470-1. PubMed ID: 23234592
    [No Abstract]   [Full Text] [Related]  

  • 20. Priapism associated with risperidone in a 21-year-old male with autism.
    Pradhan T; Hardan A
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):367-8. PubMed ID: 23738870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.